1,614
Views
480
CrossRef citations to date
0
Altmetric
Review

The Role of Tea in Human Health: An Update

, PhD & , PhD, FACN
Pages 1-13 | Received 22 Jun 2001, Accepted 30 Sep 2001, Published online: 21 Jun 2013

REFERENCES

  • Yang C, Landau J: Effects of tea consumption on nutrition and health. J Nutr 130: 2409–2412, 2000.
  • Yang C, Chung J, Yang G, Chhabra S, Lee M: Tea and tea polyphenols in cancer prevention. J Nutr 130: 472S–478S, 2000.
  • Trevisanato S, Kim Y: Tea and health. Nutr Rev 58: 1–10, 2000.
  • Hollman P, Feskens E, Katan M: Tea flavonols in cardiovascular disease and cancer epidemiology. Proc Soc Exp Biol Med 220: 198–202, 1999.
  • Kuroda Y, Hara Y: Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res 436: 69–97, 1999.
  • Bushman J: Green tea and cancer in humans: a review of the literature. Nutr Cancer 31: 151–159, 1998.
  • Kohlmeier L, Weterings K, Steck S, Kok F: Tea and cancer prevention: an evaluation of the epidemiologic literature. Nutr Cancer 27: 1–13, 1997.
  • Mitscher L, Jung M, Shankel D, Dou J, Steele L, Pillai S: Chemoprotection: A review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents. Med Res Rev 17: 327–365, 1997.
  • Tijburg L, Mattern T, Folts J, Weisgerber U, Katan M: Tea flavonoids and cardiovascular diseases: a review. Crit Rev Food Sci Nutr 37: 771–785, 1997.
  • Dreosti I, Wargovich M, Yang C: Inhibition of carcinogenesis by tea: The evidence from experimental studies. Crit Rev Food Sci Nutr 37: 761–770, 1997.
  • Vinson J, Dabbagh Y, Serry M, Jang J: Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease. J Agri Food Chem 43: 2800–2802, 1995.
  • Wehrwein P: More evidence that tea is good for the heart. Lancet 353: 384, 1999.
  • Hakim I, Weisgerber U, Harris R, Balentine D, van-Mierlo C, Paetau-Robinson I: Preparation, composition and consumption patterns of tea-based beverages in Arizona. Nutr Res 20: 1715–1724, 2000.
  • Arts I, van De Putte B, Hollman O: Catechin contents of foods commonly consumed in the Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J Agri Food Chem 48: 1752–1757, 2000.
  • Leenen R, Roodenburg A, Tijburg L, Wiseman S: A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr 54: 87–92, 2000.
  • van het Hof K, Kivits G, Weststrate J, Tijburg L: Bioavailability of catechins from tea: the effect of milk. Eur J Clin Nutr 52: 356–359, 1998.
  • Hollman PC, Van Het Hof KH, Tijburg LB, Katan MB: Addition of milk does not affect the absorption of flavonols from tea in man. Free Radic Res 34: 297–300, 2001.
  • Langley-Evans S: Antioxidant potential of green and black tea determined using the ferric reducing power (FRAP) assay. Int J Food Sci Nutr 51: 181–188, 2000.
  • Serafini M, Ghiselli A, Ferro-Luzzi A: In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 50: 28–32, 1996.
  • Tewari S, Gupta V, Bhattacharya S: Comparative study of antioxidant potential of tea with and without additives. Indian J Physiol Pharmacol 44: 215–219, 2000.
  • Langley-Evans SC: Consumption of black tea elicits an increase in plasma antioxidant potential in humans. Int J Food Sci Nutr 51: 309–315, 2000.
  • Miller N, Castelluccio C, Tijburg L, Rice-Evans C: The antioxidant properties of theaflavins and their gallate esters—radical scavengers or metal chelators? FEBS Letters 392: 40–44, 1996.
  • van Acker S, van Balen G, van den Berg D, Bast A, van der Vijgh W: Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol 56: 935–943, 1998.
  • Cao G, Sofic E, Prior R: Antioxidant capacity of tea and common vegetables. J Agri Food Chem 44: 3426–3431, 1996.
  • Rice-Evans C, Miller N, Bolwell P, Bramley P, Pridham J: The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 22: 375–383, 1995.
  • Robinson E, Maxwell S, Thorpe G: An investigation of the antioxidant activity of black tea using enhanced chemiluminescence. Free Radic Res 26: 291–302, 1997.
  • Prior R, Cao G: Antioxidant capacity and polyphenolic components of teas: Implications for altering in vivo antioxidant status. Proc Soc Exp Biol Med 220: 255–261, 1999.
  • Benzie I, Szeto Y, Strain J, Tomlinson B: Consumption of green tea causes rapid increase in plasma antioxidant power in humans. Nutr Cancer 34: 83–87, 1999.
  • Sung H, Nah J, Chun S, Park H, Yang S, Min W: In vivo antioxidant effect of green tea. Eur J Clin Nutr 54: 527–529, 2000.
  • Pietta P, Simonetti P, Gardana C, Brusamolino A, Morazzoni P, Bombardelli E: Relationship between rate and extent of catechin absorption and plasma antioxidant status. Biochem Mol Biol Int 46: 895–903, 1998.
  • Pietta P, Simonetti P, Gardana C, Brusamolino A, Morazzoni P, Bombardelli E: Catechin metabolites after intake of green tea infusions. Biofactors 8: 111–118, 1998.
  • Nakagawa K, Ninomiya M, Okubo T, Aoi N, Juneja L, Kim M, Yamanaka K, Miyazawa T: Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans. J Agri Food Chem 47: 3967–3973, 1999.
  • Klaunig J, Xu Y, Han C, Kamendulis L, Chen J, Heiser C, Gordon M, Mohler E: The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med 220: 249–254, 1999.
  • Lean M, Noroozi M, Kelly I, Burns J, Talwar D, Sattar N, Crozier A: Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes 48: 176–181, 1999.
  • Freese R, Basu S, Hietanen E, Nair J, Nakachi K, Bartsch H, Mutanen M: Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females. Eur J Nutr 38: 149–157, 1999.
  • Hertog M, Feskens E, Hollman P, Katan M, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen Elderly Study. Lancet 342, 1993.
  • Hertog M, Feskens E, Kromhout D: Antioxidant flavonols and coronary heart disease risk. Lancet 349: 699, 1997.
  • Keli S, Hertog M, Feskens E, Kromhout D: Flavonoids, antioxidant vitamins and risk of stroke. The Zutphen Study. Arch Intern Med 154: 637–642, 1995.
  • Hertog M, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic B, Toshima H, Feskens E, Hollman P, Katan M: Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 155: 381–386, 1995.
  • Sesso H, Gaziano J, Buring J, Hennekens C: Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol 149: 162–167, 1999.
  • Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K: Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13: 49–54, 2000.
  • Hertog M, Sweetnam P, Fehily A, Elwood P, Kromhout D: Antioxidant flavanols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 65: 1489–1494, 1997.
  • Woodward M, Tunstall-Pedoe H: Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 53: 481–487, 1999.
  • Peters U, Poole C, Arab L: Does tea affect cardiovascular disease? A meta-analysis. J Epidemiol, in press, 2001.
  • Geleijnse J, Launer L, Hofman A, Pols H, Witteman J: Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med 159: 2170–2174, 1999.
  • Sasazuki S, Kodama H, Yoshimasu K, Liu Y, Washio M, Tanaka K, Tokunaga S, Kono S, Arai H, Doi Y, Kawano T, Nakagaki O, Takada, Koyanagi S, Hiyamuta K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A: Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 10: 401–408, 2000.
  • Olthof MR, Hollman PC, Zock PL, Katan MB: Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am J Clin Nutr 73: 532–538, 2001.
  • Jacques PF, Bostom AG, Wilson PWF, Rich S, Rosenberg IH, Selhub J: Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73: 613–621, 2001.
  • Nygard O, Refsum H, Ueland PM, Stensvold I, Nordrehaug JE, Kvale G, Vollset SE: Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr 65: 136–143, 1997.
  • De Bree A, Verschuren WM, Blom HJ, Kromhout D: Lifestyle factors and plasma homocysteine concentrations in a general population. Am J Epi 2001; 154: 150–154.
  • Hara Y: “Green Tea: Health Benefits and Applications.” New York: Marcel Dekker pp 139–148, 2001.
  • Stensvold I, Tverdal A, Solvoll K, Foss O: Tea consumption, relationship to cholesterol, blood pressure and coronary artery disease mortality. Prev Med 21: 546–553, 1992.
  • Wakabayashi K, Kono S, Shinchi K, Honjo S, Todoroki I, Sakurai Y, Umeda T, Imanishi K, Yoshizawa N: Habitual coffee consumption and blood pressure: A study of self-defense officials in Japan. Eur J Epidemiol 14: 669–673, 1998.
  • Hodgson J, Puddey I, Burke V, Beilin L, Jordan N: Effects on blood pressure of drinking green and black tea. J Hypertension 17: 457–463, 1999.
  • Bingham S, Vorster H, Jerling J, Magee E, Mulligan A, Runswick S, Cummings J: Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr 78: 41–55, 1997.
  • Duffy SJ, Keaney Jr JF, Holbrook M, Gokce N, Swerdloff P, Frei B, Vita JA: Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001; 104; 151–156.
  • McAnlis G, McEneny J, Pearce J, Young I: Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr 52: 202–206, 1998.
  • Cherubini A, Beal M, Frei B: Black tea increases the resistance of human plasma to lipid peroxidation in vitro, but not ex vivo. Free Radic Biol Med 27: 381–387, 1999.
  • Princen H, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg L, Langius J, Meinders A, Pijl H: No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 18: 833–841, 1998.
  • van het Hof K, de Boer H, Wiseman S, Lien N, Westrate J, Tijburg L: Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 66: 1125–1132, 1997.
  • Lotto S, Fraga C: Catechins delay lipid oxidation and a-tocopherol and b-carotene depletion following ascorbate depletion in human plasma. Proc Soc Exp Biol Med 225: 32–38, 2000.
  • Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayaori M, Nishiwaki M, Yonemura A, Hara Y, Nakamura H: Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 66: 261–266, 1997.
  • Hodgson J, Puddey I, Croft K, Burke V, Mori T, Caccetta R, Beilin L: Acute effects of ingestion of black and green tea on lipoprotein oxidation. Am J Clin Nutr 71: 1103–1107, 2000.
  • van het Hof K, Wiseman S, Yang C, Tijburg L: Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc Soc Exp Biol Med 220: 203–209, 1999.
  • Miura Y, Chiba T, Miura S, Tomita I, Umegaki K, Ikeda M, Tomita T: Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: an ex vivo study in humans. J Nutr Biochem 11: 216–222, 2000.
  • Pearson D, Frankel E, Aeschbach R, German J: Inhibition of endothelial cell mediated low-density lipoprotein oxidation by green tea extracts. J Agri Food Chem 46: 1445–1449, 1998.
  • Luo M, Kannar K, Wahlquist M, O’Brien R: Inhibition of LDL oxidation by green tea extract. Lancet 349: 360–361, 1997.
  • Scalbert A, Williamson G: Dietary intake and bioavailability of polyphenols. J Nutr 130: 2073S–2085S, 2000.
  • Li C, Lee M, Sheng S, Meng X, Prabhu S, Winnik B, Huang B, Chung J, Yan S, Ho C, Yang C: Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol 13: 177–184, 2000.
  • Loktionov A, Bingham S, Vorster H, Jerling J, Runswick S, Cummings J: Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br J Nutr 79: 133–139, 1998.
  • Kang W, Lim I, Yuk D, Chung K, Park J, Yoo H, Yun Y: Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res 96: 229–237, 1999.
  • Ahmad N, Mukhtar H: Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev 57: 78–83, 1999.
  • Fujiki H, Suganuma M, Okabe S, Sueoka N, Komori A, Sueoka E, Kozu T, Tada Y, Suga K, Imai K, Nakachi K: Cancer inhibition by green tea. Mutat Res 402: 307–310, 1998.
  • Zheng W, Doyle T, Kushi L: Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 144: 175–181, 1996.
  • Goldbohm R, Hertog M, Brants H, van Poppel G, van den Brandt P: Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst 88: 93–100, 1996.
  • Tavani A, Pregnolato A, La Vecchia C, Favero A, Franceschi S: Coffee consumption and the risk of breast cancer. Eur J Cancer Prev 7: 77–82, 1998.
  • Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y: Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 89: 254–256, 1998.
  • Nagata C, Kabuto M, Shimizu H: Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer 30: 21–24, 1998.
  • Kinjo Y, Cui Y, Akiba S, Watanabe S, Yamaguchi N, Sobue T, Mizuno S, Beral V: Mortality risks of oesophageal cancer associated with hot tea, alcohol, tobacco and diet in Japan. J Epidemiol Community Health 8: 235–243, 1998.
  • Mendilaharsu M, De Stefani E, Deneo-Pellegrini H, Carzoglio J, Ronco A: Consumption of tea and coffee and the risk of lung cancer in cigarette-smoking men: a case-control study in Uruguay. Lung Cancer 19: 101–107, 1998.
  • Hertog M, Feskens E, Hollman P, Katan M, Kromhout D: Dietary flavonoids and cancer risk in the Zutphen elderly study. Nutr Cancer 22: 175–184, 1994.
  • Le Marchand L, Murphy S, Hankin J, Wilkens L, Kolonel L: Intake of flavonoids and lung cancer. J Natl Cancer Inst 92: 154–159, 2000.
  • Chow W, Swanson C, Lissowska J, Groves F, Sobin L, Nasierowska-Guttmejer A, Radziszewski J, Regula J, Hsing A, Jagannatha S, Zatonski W, Blot W: Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int J Cancer 81: 871–876, 1999.
  • Hibasami H, Komiya T, Achiwa Y, Ohnishi K, Kojima T, Nakanishi K, Sugimoto Y, Hasegawa M, Akatsuka R, Hara Y: Black tea theaflavins induce programmed cell death in cultured human stomach cancer cells. Int J Mol Med 1: 725–727, 1998.
  • Tajima K, Tominaga S: Dietary habits and gastro-intestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Jpn J Cancer Res 76: 705–716, 1985.
  • Yu G, Hsieh C, Wang L, Yu S, Li X, Jin T: Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control 6: 532–538, 1995.
  • Inoue M, Tajima K, Hirose K, Hamajima N, Takezaki T, Kuroishi T, Tominaga S: Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control 9: 209–216, 1998.
  • Shibata K, Moriyama M, Fukushima T, Kaetsu A, Miyazaki M, Une H: Green tea consumption and chronic atrophic gastritis: a cross-sectional study in a green tea production village. J Epidemiol 10: 310–316, 2000.
  • Hamajima N, Tajima K, Tominaga S, Matsuura A, Kuwabara M, Okuma K: Tea polyphenol intake and changes in serum pepsinogen levels. Jpn J Cancer Res 90: 136–143, 1999.
  • Tsubono Y, Nishino Y, Komatsu S, Hsieh C, Kanemura S, Tsuji I, Nakatsuka H, Fukao A, Satoh H, Hisamichi S: Green tea and the risk of gastric cancer in Japan. N Engl J Med 344: 632–636, 2001.
  • August D, Landau J, Caputo D, Hong J, Lee M, Yang C: Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiol Biomarkers Prev 8: 709–713, 1999.
  • Baron J, Gerhardsson de Verdier M, Ekbom A: Coffee, tea, tobacco, and cancer of the large bowel. Cancer Epidemiol Biomarkers Prev 3: 565–570, 1994.
  • Hartman T, Tangrea J, Pietinen P, Malila N, Virtanen M, Taylor P, Albanes D: Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish men. Nutr Cancer 31: 41–48, 1998.
  • Muñoz S, Navarro A, Lantieri M, Fabro M, Peyrano M, Ferraroni M, Decarli A, La Vecchia C, Eynard A: Alcohol, methylxanthine-containing beverages, and colorectal cancer in Cordoba, Argentina. Eur J Cancer Prev 7: 207–213, 1998.
  • Ohno Y, Aoki K, Obata K, Morrison A: Case-control study of urinary bladder cancer in metropolitan Nagoya. In NCI Monograph 69. Bethesda: National Cancer Institute, pp 229–234, 1985.
  • Wakai K, Ohno Y, Obata K, Aoki K: Prognostic significance of selected lifestyle factors in urinary bladder cancer. Jpn J Cancer Res 84: 1223–1229, 1993.
  • Nagano J, Kono S, Preston D, Moriwaki H, Sharp G, Koyama K, Mabuchi K: Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors. Int J Cancer 86: 132–138, 2000.
  • Bianchi G, Cerhan J, Parker A, Putnam S, See W, Lynch C, Cantor K: Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. Am J Epidemiol 151: 377–383, 2000.
  • Lu C, Lan S, Lee Y, Huang J, Huang C, Hsieh C: Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan. Urology 54: 823–828, 1999.
  • Liao S, Hiipakka RA: Selective inhibition of steroid 5 α-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun 1995; 214: 833–888.
  • Jain M, Hislop G, Howe G, Burch J, Ghadirian P: Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer 78: 707–711, 1998.
  • Ellison L: Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur J Cancer Prev 9: 125–130, 2000.
  • Paschka A, Butler R, Young C: Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 130: 1–7, 1998.
  • Zhao J, Zhang Y, Jin X, Athar M, Santella R, Bickers D, Wang Z: Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin. J Invest Dermatol 113: 1070–1075, 1999.
  • Katiyar S, Matsui M, Elmets C, Mukhtar H: Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol 69: 148–153, 1999.
  • Katiyar SK, Afaq F, Peez A, Mukhtar H: Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 22: 287–294, 2001.
  • Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H: Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 44: 425–432, 2001.
  • Zhao J, Jin X, Yaping E, Zheng Z, Zhang Y, Athar M, DeLeo V, Mukhtar H, Bickers D, Wang Z: Photoprotective effect of black tea extracts against UVB-induced phototoxicity in skin. Photochem Photobiol 70: 637–644, 1999.
  • Hakim I, Harris R, Weisgerber U: Tea intake and squamous cell carcinoma of the skin: Influence of type of tea beverages. Cancer Epidemiol Biomarkers Prev 9: 727–731, 2000.
  • Uehara M, Sugiura H, Sakurai K: A trial of oolong tea in the management of recalcitrant atopic dermatitis. Arch Dermatol 137: 42–43, 2001.
  • Li N, Sun Z, Han C, Chen J: The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proc Soc Exp Biol Med 220: 218–224, 1999.
  • Yang C, Lee M, Chen L: Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Cancer Epidemiol Biomarkers Prev 8: 83–89, 1999.
  • Jones C, Woods K, Whittle G, Worthington H, Taylor G: Sugar, drinks, deprivation and dental caries in 14-year-old children in the north west of England in 1995. Community Dent Health 16: 68–71, 1999.
  • Kavanagh D, Renehan J: Fluoride in tea—its dental significance: a review. J Ir Dent Assoc 44: 100–105, 1998.
  • Rasheed A, Haider M: Antibacterial activity of Camellia sinensis extracts against dental caries. Arch Pharm Res 21: 348–352, 1998.
  • Matsumoto M, Minami T, Sasaki H, Sobue S, Hamada S, Ooshima T: Inhibitory effects of oolong tea extract on caries-inducing properties of mutans streptococci. Caries Res 33: 441–445, 1999.
  • Zhang J, Kashket S: Inhibition of salivary amylase by black and green teas and their effects on the intraoral hydrolysis of starch. Caries Res 32: 233–238, 1998.
  • Sharquie KE, al-Turfi IA, al-Salloum SM: The antibacterial activity of tea in vitro and in vivo in patients with impetigo contagiosa. J Dermatol 27: 706–710, 2000.
  • Johnell O, Gullberg B, Kanis J, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G: Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res 10: 1802–1815, 1995.
  • Kanis J, Johnell O, Gullberg B, Allander E, Elffors L, Ranstam J, Dequeker J, Dilsen G, Gennari C, Vaz A, Lyritis G, Mazzuoli G, Miravet L, Passeri M, Perez Cano R, Rapado A, Ribot C: Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int 9: 45–54, 1999.
  • Hegarty V, May H, Khaw K: Tea drinking and bone mineral density in older women. Am J Clin Nutr 71: 1003–1007, 2000.
  • Dulloo A, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J: Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70: 1040–1045, 1999.
  • Rogers M, Simon D: A preliminary study of dietary aluminum intake and risk of Alzheimer’s disease. Age Ageing 28: 205–209, 1999.
  • Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF: Intake of flavonoids and risk of dementia. Eur J Epidemiol 16: 357–363, 2000.
  • Hindmarch I, Rigney U, Stanley N, Quinlan P, Rycroft J, Lane J: A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology (Berl) 149: 203–216, 2000.
  • Hurrell RF, Reddy M, Cook JD: Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. Br J Nutr 1999; 81: 289–295.
  • al-Othaimeen A, Osman A, al Orf S: Prevalence of nutritional anaemia among primary school girls in Riyadh City, Saudi Arabia. Int J Food Sci Nutr 50: 237–243, 1999.
  • Gibson S: Iron intake and iron status of preschool children: associations with breakfast cereals, vitamin C and meat. Public Health Nutr 2: 521–528, 1999.
  • Kaltwasser J, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C: Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut 43: 699–704, 1999.
  • Samman S, Sandström, Toft MB, Bukhave K, Jensen M, Sorensen SS, Hansen M: Green tea or rosemary extract added to foods reduces nonheme-iron absorption. Am J Clin Nutr 73: 607–612, 2001.
  • Erba D, Riso P, Colombo A, Testolin G: Supplementation of Jurkat T cells with green tea extract decreases oxidative damage due to iron treatment. J Nutr 129: 2130–2134, 1999.
  • Massey L: Tea oxalate. Nutr Rev 58: 88–89, 2000.
  • Curhan G, Willett W, Speizer F, Stampfer M: Beverage use and risk for kidney stones in women. Ann Intern Med 128: 534–540, 1998.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.